CDH1 and prostate carcinoma: We found a reduction in NF-κB (p65), IL-1β, and Vimentin and upregulation of E-cadherin protein levels in MTA1 knockdown (shMTA1) prostate cancer cells (Figure 2A and 2B), suggesting direct involvement of MTA1 in inflammation and EMT in prostate cancer.